Frontiers in Immunology (Jul 2025)
Correction: EBV-positive diffuse large B cell lymphoma secondary to activated phosphoinositide 3 kinase δ syndrome type 1 (APDS1): a case report and literature review
Abstract
No abstracts available.Keywords
Frontiers in Immunology (Jul 2025)